Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Daniel B. Bailey"'
Autor:
Robert S. Seitz, Michael E. Hurwitz, Tyler J. Nielsen, Daniel B. Bailey, Matthew G. Varga, Brian Z. Ring, Carrie F. Metts, Brock L. Schweitzer, Kimberly McGregor, Douglas T. Ross
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background The IO Score is a 27-gene immuno-oncology (IO) classifier that has previously predicted benefit to immune checkpoint inhibitor (ICI) therapy in triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC). It genera
Externí odkaz:
https://doaj.org/article/559b3f8416ed47f4ba8dbc1a517b7989
Autor:
Kenichi Harano, Ying Wang, Bora Lim, Robert S Seitz, Stephan W Morris, Daniel B Bailey, David R Hout, Rachel L Skelton, Brian Z Ring, Hiroko Masuda, Arvind U K Rao, Steven Van Laere, Francois Bertucci, Wendy A Woodward, James M Reuben, Savitri Krishnamurthy, Naoto T Ueno
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204513 (2018)
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen
Externí odkaz:
https://doaj.org/article/d68e3061b3564009845c351904eed6a8
Autor:
Kim R. M. Blenman, Xiang Zhang, Robert S. Seitz, Yichao Shen, Daniel B. Bailey, Toshiaki Iwase, Tyler J. Nielsen, Brock L. Schweitzer, Xiaotong Li, Emily Reisenbichler, David R. Hout, Naoto T. Ueno, Lajos Pusztai
Publikováno v:
Cancers, Vol 13, Iss 4839, p 4839 (2021)
Cancers
Volume 13
Issue 19
Cancers
Volume 13
Issue 19
A precise predictive biomarker for TNBC response to immunochemotherapy is urgently needed. We previously established a 27-gene IO signature for TNBC derived from a previously established 101-gene model for classifying TNBC. Here we report a pilot stu
Autor:
Daniel B. Bailey, Sung-Wook Kwon
Publikováno v:
The Social Science Journal. 56:107-117
As sustainable development is becoming more important to ensure the economic success and social well-being of any government, without regard to its level, the efficient use and protection of natural resources has increased in importance. And local go
Autor:
Roy A. Jensen, Ryan M. Ash, Sajjad Bhatti, Qamar J. Khan, Rob Seitz, Daniel B. Bailey, Carolyn Lehn, Fang Fan, Andrew K. Godwin, David R. Hout, Jaimie Heldstab, Anne O'Dea, Priyanka Sharma, Ossama Tawfik
Publikováno v:
JCO Precision Oncology. :1-6
Autor:
Yichao Shen, Xiang Zhang, Robert S. Seitz, Daniel B. Bailey, Tyler J. Nielsen, David R. Hout, Lajos Pusztai, Kim Blenman, Toshiaki Iwase, Brock L. Schweitzer, Xiaotong Li, Naoto T. Ueno
Publikováno v:
Journal of Clinical Oncology. 38:3117-3117
3117 Background: A 101-gene algorithm established as a molecular subtyping method for triple-negative breast cancer (TNBC) includes assignment of an immunomodulatory (IM) subtype based on genes active in immune cell processes. Recently, we isolated t
Autor:
Steven Van Laere, Arvind Rao, Savitri Krishnamurthy, Brian Z. Ring, David R. Hout, Robert S. Seitz, Wendy A. Woodward, Kenichi Harano, Ying Wang, Daniel B. Bailey, Stephan W. Morris, Hiroko Masuda, Rachel Skelton, Naoto T. Ueno, Bora Lim, François Bertucci, James M. Reuben
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204513 (2018)
PLoS ONE
PLoS ONE, Public Library of Science, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩
PLoS ONE, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩
PLoS ONE
PLoS ONE, Public Library of Science, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩
PLoS ONE, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩
International audience; In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M
Autor:
Brian Z. Ring, David R. Hout, Stephan W. Morris, Kasey Lawrence, Brock L. Schweitzer, Daniel B. Bailey, Brian D. Lehmann, Jennifer A. Pietenpol, Robert S. Seitz
Publikováno v:
BMC Cancer
Recently, a gene expression algorithm, TNBCtype, was developed that can divide triple-negative breast cancer (TNBC) into molecularly-defined subtypes. The algorithm has potential to provide predictive value for TNBC subtype-specific response to vario
Autor:
David R. Hout, Brian D. Lehmann, Brian Z. Ring, Daniel B. Bailey, Kasey Lawrence, Stephan W. Morris, Jennifer A. Pietenpol, Brock L. Schweitzer, Robert S. Seitz
Publikováno v:
BMC Cancer
Background Recently, a gene expression algorithm, TNBCtype, was developed that can divide triple-negative breast cancer (TNBC) into molecularly-defined subtypes. The algorithm has potential to provide predictive value for TNBC subtype-specific respon
Publikováno v:
Journal of Clinical Oncology. 35:e23073-e23073
e23073 Background: Lehmann and colleagues (Lehmann 2011) devised a classification system for triple negative breast cancer (TNBC) consisting of seven subtypes—IM, BL1, BL2, LAR, M, MSL, and UNS. Recent work has shown the IM group (characterized by